BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 30052620)

  • 1. Clinical Significance of G Protein-Coupled Receptor 110 (GPR110) as a Novel Prognostic Biomarker in Osteosarcoma.
    Liu Z; Zhang G; Zhao C; Li J
    Med Sci Monit; 2018 Jul; 24():5216-5224. PubMed ID: 30052620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammasome-related gene signatures as prognostic biomarkers in osteosarcoma.
    Zhang N; Han Y; Cao H; Wang Q
    J Cell Mol Med; 2024 May; 28(9):e18286. PubMed ID: 38742843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma.
    Guo T; Wei R; Dean DC; Hornicek FJ; Duan Z
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34984436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of integrin-binding sialoprotein (IBSP) is associated with poor prognosis of osteosarcoma.
    Ma Y; Chen B; Zhang B; Zhang C; Zhu Q; Wang X; Liu Z; Liu H
    Aging (Albany NY); 2023 Nov; 16(1):28-42. PubMed ID: 38006395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for identifying physiologically relevant binding proteins of G-protein-coupled receptors.
    Huang BX; Kim HY
    STAR Protoc; 2023 Dec; 4(4):102691. PubMed ID: 37925637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction: SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma.
    Biosci Rep; 2023 Nov; 43(11):. PubMed ID: 37921048
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of aberrant G protein-couple receptor 110 (GPR110) expression in gastric cancer.
    Zhu X; Huang G; Jin P
    Pathol Res Pract; 2019 Mar; 215(3):539-545. PubMed ID: 30638950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptamide activates the adhesion GPCR GPR110 (ADGRF1) through GAIN domain binding.
    Huang BX; Hu X; Kwon HS; Fu C; Lee JW; Southall N; Marugan J; Kim HY
    Commun Biol; 2020 Mar; 3(1):109. PubMed ID: 32144388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic studies of synaptamide in an immortalized dopaminergic cell line.
    Sonti S; Tolia M; Duclos RI; Loring RH; Gatley SJ
    Prostaglandins Other Lipid Mediat; 2019 Apr; 141():25-33. PubMed ID: 30763677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (
    Wu M; Lo TH; Li L; Sun J; Deng C; Chan KY; Li X; Yeh ST; Lee JTH; Lui PPY; Xu A; Wong CM
    Elife; 2023 Aug; 12():. PubMed ID: 37580962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion G protein-coupled receptors: structure, signaling, physiology, and pathophysiology.
    Lala T; Hall RA
    Physiol Rev; 2022 Oct; 102(4):1587-1624. PubMed ID: 35468004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction and Identification of GPCRs Targeting for Drug Repurposing in Osteosarcoma.
    Tan M; Gao S; Ru X; He M; Zhao J; Zheng L
    Front Oncol; 2022; 12():828849. PubMed ID: 35463319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of tethered agonism of the adhesion GPCRs ADGRD1 and ADGRF1.
    Qu X; Qiu N; Wang M; Zhang B; Du J; Zhong Z; Xu W; Chu X; Ma L; Yi C; Han S; Shui W; Zhao Q; Wu B
    Nature; 2022 Apr; 604(7907):779-785. PubMed ID: 35418679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Gαi3 as a promising target for osteosarcoma treatment.
    Bian ZJ; Shan HJ; Zhu YR; Shi C; Chen MB; Huang YM; Wang XD; Zhou XZ; Cao C
    Int J Biol Sci; 2022; 18(4):1508-1520. PubMed ID: 35280670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Analysis of Microarray and RNA-Seq Data for the Identification of Hub Genes and Networks Involved in the Pancreatic Cancer.
    Nisar M; Paracha RZ; Arshad I; Adil S; Zeb S; Hanif R; Rafiq M; Hussain Z
    Front Genet; 2021; 12():663787. PubMed ID: 34262595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer.
    Abdulkareem NM; Bhat R; Qin L; Vasaikar S; Gopinathan A; Mitchell T; Shea MJ; Nanda S; Thangavel H; Zhang B; De Angelis C; Schiff R; Trivedi MV
    FASEB J; 2021 Jul; 35(7):e21719. PubMed ID: 34110646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of adhesion G protein-coupled receptor activation.
    Vizurraga A; Adhikari R; Yeung J; Yu M; Tall GG
    J Biol Chem; 2020 Oct; 295(41):14065-14083. PubMed ID: 32763969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of GPR110 in lung cancer progression.
    Ma B; Zhu J; Su J; Pan F; Ji Y; Luan L; Huang J; Hou Y
    Ann Transl Med; 2020 Jun; 8(12):745. PubMed ID: 32647670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emerging Role of Adhesion GPCRs in Cancer.
    Gad AA; Balenga N
    ACS Pharmacol Transl Sci; 2020 Feb; 3(1):29-42. PubMed ID: 32259086
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.